Does ETEPLIRSEN Cause Product dose omission issue? 641 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 641 reports of Product dose omission issue have been filed in association with ETEPLIRSEN (Exondys 51). This represents 30.8% of all adverse event reports for ETEPLIRSEN.
641
Reports of Product dose omission issue with ETEPLIRSEN
30.8%
of all ETEPLIRSEN reports
0
Deaths
26
Hospitalizations
How Dangerous Is Product dose omission issue From ETEPLIRSEN?
Of the 641 reports, 26 (4.1%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETEPLIRSEN. However, 641 reports have been filed with the FAERS database.
What Other Side Effects Does ETEPLIRSEN Cause?
No adverse event (503)
Intentional dose omission (259)
Poor venous access (162)
Device issue (156)
Pyrexia (85)
Covid-19 (83)
Malaise (56)
Cough (53)
Fall (53)
Pneumonia (51)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ETEPLIRSEN Alternatives Have Lower Product dose omission issue Risk?
ETEPLIRSEN vs ETESEVIMAB
ETEPLIRSEN vs ETHACRYNIC ACID
ETEPLIRSEN vs ETHAMBUTOL
ETEPLIRSEN vs ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN
ETEPLIRSEN vs ETHANOL